Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Global Epidemiology|December 3, 2025
Physical activity patterns and environmental influences: Findings from the Kuwait diabetes epidemiology programVictor M Oguoma, Mark Daniel, Ralf-D Schroers, et al.
Plos One|December 14, 2020
HIV/AIDS knowledge and attitudes assessment among women of child-bearing age in South Sudan: Findings from a Household SurveyWilliam Mude, Victor M Oguoma, Hailay Abrha Gesesew, et al.
BMC Public Health|January 8, 2017
Cardiovascular disease risk factors in a Nigerian population with impaired fasting blood glucose level and diabetes mellitusVictor M Oguoma, Ezekiel U Nwose, Ifeoma I Ulasi, et al.
Heart, Lung & Circulation|February 10, 2026
Participation of Aboriginal and Torres Strait Islander People in Conventional Cardiac Rehabilitation Programs: Analysis of the Queensland Cardiac Outcomes RegistryEmma E Thomas, Michael Le Grande, Lidya A Jokhu, et al.
Pediatric Pulmonology|February 26, 2020
A decade on: Follow-up findings of indigenous children with bronchiectasisGabrielle B McCallum, Rosalyn J Singleton, Gregory J Redding, et al.
BMC Pediatrics|March 9, 2021
Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, et al.
The Lancet. Child & Adolescent Health|May 26, 2020
Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort studyMichael J Binks, Jemima Beissbarth, Victor M Oguoma, et al.
BMJ Global Health|May 7, 2026
Alarming disparities of adolescent motherhood in Nigeria: results from 36 states and the Federal Capital TerritoryAnayochukwu E Anyasodor, M Mamun Huda, Md Mahmudur Rahman, et al.
Vaccine: X|March 8, 2021
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, et al.
BMJ Open|May 26, 2020
10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trialVictor M Oguoma, Nicole Wilson, Kim Mulholland, et al.
Pageof 4